Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from Global Virus Network, 12901 Bruce B Downs Boulevard, Tampa, FL.
A global non-profit network of expert virologists advancing pandemic preparedness through education and training, research, and global health strategies and solutions that inform policy, foster alliances, and combat misinformation.
12/30/2025
At the 2025 in Translational Virology, Dr. Anna Giuliano (Moffitt Cancer Center) presented on the epidemiology and biology of human papillomavirus (HPV).
She explained how HPV causes multiple cancers in both women and men, why cervical cancer is uniquely preventable through routine screening, and why most other HPV-related cancers currently lack effective screening tools.
Dr. Giuliano emphasized vaccination as the most powerful strategy for preventing HPV-associated cancers worldwide.
This session highlighted how supports prevention-focused approaches that strengthen global and public health resilience.
12/29/2025
Join us in Tampa, Florida · March 2–6, 2026 for International Science Innovation Week 2026, a global gathering of leaders in science, medicine, and innovation dedicated to advancing pandemic preparedness, virology, and cancer research.
The week features the GVN Annual International Scientific Meeting – “Pandemic Preparedness?” (March 4–6), bringing together world-renowned virologists and public health experts to explore emerging threats, surveillance breakthroughs, and innovations in vaccines, therapeutics, and diagnostics.
At the 2025 in Translational Virology, GVN Co-Founder Dr. Robert Gallo (University of South Florida, USF Health-University of South Florida) reflected on the discoveries that led to the identification of HTLV-1 and HIV.
He explained how advances in T-cell culture, interleukin-2, and immortalized CD4+ cell lines made it possible to grow large amounts of virus and develop the first HIV antibody tests.
These breakthroughs transformed blood safety, enabled global tracking of the virus, and reshaped how viral diseases are detected and studied worldwide.
This historical perspective underscored how drives scientific breakthroughs that continue to strengthen global .
12/28/2025
News Medical highlights the Global Virus Network’s expert statement outlining priority actions as Marburg virus emerges in Ethiopia, emphasizing the urgent need for surveillance, rapid diagnostics, contact tracing, and sustained investment in research.
The article features GVN experts discussing vaccine and therapeutic research gaps, regional implications, and the importance of strong scientific partnerships across Africa to strengthen preparedness and response.
The Global Virus Network (GVN), a coalition of leading human and animal virologists in more than 40 countries dedicated to advancing pandemic preparedness through research, education and training, and global health solutions, today issued a statement on the newly confirmed outbreak of Marburg virus....
12/27/2025
La Dépêche du Midi highlights concerns that the 2025 flu season may be particularly virulent, citing expert analysis from the Global Virus Network on the early spread of the H3N2 subclade K variant.
The article references GVN’s assessment that this drifted influenza strain has accumulated mutations that may increase transmissibility and allow partial immune escape, while reinforcing that vaccination remains the most effective tool to prevent severe illness and reduce pressure on health systems.
L’épidémie de grippe serait particulièrement précoce cette année, signe avant-coureur d’une épidémie plus virulente. Une nouvelle souche de grippe A (H3N2) a également émergé. Celle-ci aurait accumulé des mutations la...
12/26/2025
At the 2025 in Translational Virology, Dr. Hongshuo Song (University of South Florida, USF Health-University of South Florida) explained how HIV evolves from the moment of transmission to global population-level diversity.
She described how rapid mutation and recombination allow the virus to escape immune responses within individuals and generate many different HIV subtypes worldwide.
Dr. Song highlighted key concepts such as transmission bottlenecks, coreceptor switching, and subtype differences, and explained why HIV genetic diversity presents major challenges for treatment strategies and vaccine development.
By strengthening foundational understanding of viral evolution, this session reinforced as essential to building scientific capacity for long-term .
12/25/2025
Call for Abstracts Now Open!
The Global Virus Network (GVN) invites researchers, clinicians, trainees, and public health professionals to submit abstracts for the 2026 GVN Annual International Scientific Meeting, “Pandemic Preparedness?”, taking place March 4–6, 2026 in Tampa, Florida.
We welcome cutting-edge work in virology, infectious diseases, global health, and interdisciplinary scientific innovation. Early-career investigators and applicants from low- and middle-income countries are especially encouraged to apply. Up to 10 travel awards will be available.
Submission Deadline: January 15, 2026
Full details, eligibility, and guidelines: https://ow.ly/WeX850XGUX1
We look forward to reviewing your submissions and advancing global collaboration in pandemic preparedness.
12/25/2025
At the 2025 in Translational Virology, Dr. Gene Morse (University at Buffalo) shared insights on today’s research funding environment.
He discussed why successful research increasingly depends on multidisciplinary teams, strong partnerships, and clear alignment with global and local health priorities.
Dr. Morse encouraged early-career scientists to think strategically about collaboration, focus, and long-term research capacity when navigating grants and funding opportunities.
By preparing early-career researchers to build sustainable programs, this session underscored how strengthens scientific capacity needed for long-term .
12/24/2025
At the 2025 in Translational Virology, Dr. Kami Kim (University of South Florida, USF Health-University of South Florida described how local genomic surveillance informed real-world clinical response during the COVID-19 pandemic.
She explained how knowing which variants were circulating helped hospitals adapt care, plan resources, and adjust treatment strategies across the Alpha, Delta, and Omicron waves.
Dr. Kim emphasized the role of strong multidisciplinary teams and timely local data in protecting patients, healthcare workers, and hospital systems during rapidly changing conditions.
This session demonstrated how equips clinicians and scientists with practical skills that strengthen .
12/23/2025
At the 2025 in Translational Virology, Deanna Becker (Tampa General Hospital) explained how SARS-CoV-2 genomic sequencing was used to support real-time COVID-19 decision-making at the local level.
She showed why sequencing matters beyond standard testing, how samples were selected and processed, and how results were shared through an internal dashboard that helped clinicians and hospital leadership understand which variants were circulating.
She also highlighted the importance of sharing data with public health partners to contribute to broader regional and global surveillance efforts.
By training participants to apply genomic data in real-world clinical and public health settings, this session reinforced as a foundation of effective .
Be the first to know and let us send you an email when Global Virus Network posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The Global Virus Network (GVN) was co-founded in 2011 by Robert Gallo, MD of the Institute of Human Virology at the University of Maryland School of Medicine, William Hall, MD, PhD of University College Dublin and the late Reinhard Kurth, MD, PhD, of the Robert Koch Institute. The GVN is an essential and critical defense against viral disease. It is a coalition comprised of leading virologists spanning more than 20 countries worldwide, all working to advance knowledge about how viruses make us sick and to develop drugs and vaccines to prevent illness and death. No single institution in the world has expertise in all viral areas. GVN brings the best medical virologists together to leverage individual strengths and to focus global teams of scientists on key scientific problems. The power of GVN lies in its global reach, the depth of its science, and its commitment to solving viral challenges facing the human population. No other entity exists like the GVN.
Declaration of Support for a Global Virus Network
WE, EXPERTS represent Centers of Excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind.
WE AFFIRM the need for new programs to coordinate, support and promote research that bridges the gap between virus surveillance and public health implementation.
WE GATHER in Washington, D.C. to support goals and ideals of the Global Virus Network, a new approach to fostering true collaboration among all regions and all peoples of the world.
Seeking to improve the immediate responses to emerging vial threats, train future generations of medical virologists, and advise governments or non-governmental organizations on viral disease threats and their control, the Global Virus Network fills a critical need in international health for today and into the future.
